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Objective: Multiple, short and deep inspiratory breath-
holds with air of approximately 20s are now used in
radiotherapy to reduce the influence of ventilatory
motion and damage to healthy tissue. There may be
further clinical advantages in delivering each treatment
session in only one single, prolonged breath-hold. We
have previously developed techniques enabling healthy
subjects to breath-hold for 7min. Here, we demonstrate
their successful application in patients with cancer.
Methods: 15 patients aged 37–74 years undergoing
radiotherapy for breast cancer were trained to breath-
hold safely with pre-oxygenation and mechanically
induced hypocapnia under simulated radiotherapy
treatment conditions.
Results: The mean breath-hold duration was 5.36
0.2min. At breakpoint, all patients were normocapnic
and normoxic [mean end-tidal partial pressure of carbon
dioxide was 366 1 standard error millimetre of mercury,
(mmHg) and mean oxygen saturation was 10060
standard error %]. Nonewere distressed, nor had gasping,
dizziness or disturbed breathing in the post-breath-hold
period. Mean blood pressure had risen significantly from
12563 to 16664mmHg at breakpoint (without heart rate
falling), but normalized within approximately 20s of the
breakpoint. During breath-holding, the mean linear ante-
roposterior displacement slope of the L breast marker
was ,2mmmin21.
Conclusion: Patients with cancer can be trained to
breath-hold safely and under simulated radiotherapy
treatment conditions for longer than the typical beam-
on time of a single fraction. We discuss the important
applications of this technique for radiotherapy.
Advances in knowledge: We demonstrate for the first
time a technique enabling patients with cancer to
deliver safely a single prolonged breath-hold of .5min
(10 times longer than currently used in radiotherapy
practice), under simulated radiotherapy treatment
conditions.
INTRODUCTION
Respiratory-related motion of 2–3 cm1 remains a major
problem in radiotherapy planning and delivery for most
thoracic and abdominal cancers. Such motion requires
substantial enlargement (by 1 cm or more) in the planned
treatment ﬁeld and encroachment on vital structures. This
requires management that will be especially important with
the imminent introduction of MR-guided radiotherapy.2
Koybasi et al3 report that for irregular breathing patterns,
four-dimensional CTmay inaccurately characterize tumour
motion and location, with negative consequences particularly
for treatment delivered with scanned proton beams. Fur-
thermore, the correspondence between breathing motion
assessed by four-dimensional CTat the planning stage and the
motion during each daily treatment is rarely measured in
routine clinical practice.
Gating methodologies4 appear to be accurate, but increase
the duration of treatment slots. Tracking is technically
challenging, as the latencies of critical systems such as the
multileaf collimator and associated control systems are
such that a predictive model of linear motion is required
for accurate tracking.5 Specialized techniques such as
CyberKnife® (Accuray Inc., Sunnyvale, CA) measure this
correspondence well, allowing tracking during treatment
by a combination of dynamic monitoring of the chest
surface contours with regular planar X-ray imaging of in-
ternal anatomy,6 and other approaches to tracking are
developing. Particle therapy introduces the additional challenge
of range changes, for instance should a tracked lung lesion move
in and out of the shadow of a rib.2
Currently, such motion can be addressed to a limited extent by
asking patients to breathe to a metronome or to achieve inﬂation
volumes within visible guidelines.1,7,8 But, all such techniques
depend on how well patients respond to feedback and continue
to comply with instructions. Newly emerging techniques involve
using multiple, short and deep inspiratory breath-holds with air
of approximately 20 s.1,9–13 There is, however, a simple and
practical alternative: to deliver each treatment in a single pro-
longed breath-hold.
The basic physiology of breath-holding is well understood.14,15
But, until recently, this knowledge had no clinical application
and is barely taught in medicine. For the last 5 years, .3 articles
per week in radiotherapy journals describe the application of
multiple short breath-holds without appreciating the advantages
this physiological knowledge can already offer. First, the com-
bination of training, practice, pre-oxygenation and mechanically
induced hypocapnia16 is already known to achieve mean single
breath-hold durations of 7min in healthy and experienced
volunteers17 and of .5min in inexperienced volunteers.18 Sec-
ondly, it is straightforward to incorporate limits with readily
available and non-invasive monitoring equipment18 to ensure
patient safety against the two principal risks of prolonged
breath-holds, asphyxia and raised blood pressure. Thirdly, the
cause of the slight chest deﬂation during breath-holding is al-
ready understood14 and should have a small, linear and pre-
dictable effect on chest motion.
We have used this knowledge to establish for the ﬁrst time
whether patients with cancer undergoing radiotherapy can be
trained to sustain a single prolonged breath-hold that is long
enough to deliver a single and typical radiotherapy beam-on
time (approximately 2min). We tested whether they could de-
liver it under simulated radiotherapy treatment conditions. We
also measured the three-dimensional movement of the chest
surface during the single prolonged breath-hold.
METHODS AND MATERIALS
Patient recruitment
Conduction of experiments followed the Declaration of Helsinki
and approval of the local research ethics committee. In we
trained 15 female patients with breast cancer aged 37–74 years
(mean age 54 years, with 4 patients aged 60 years or above) all
undergoing radiotherapy (Table 1), with 12 patients having re-
ceived chemotherapy (11 patients of whom had anthracycline-
based chemotherapy and 2 patients received trastuzumab). None
had respiratory, cardiovascular or neurological disease, diabetes
or obesity. All were non-smokers with no previous experience of
breath-holding.
Initial instruction and training
On the ﬁrst session (Day 1), they lay at rest on a bed and were
instrumented for safety17219 to measure the blood pressure
(Finapres 2300 Ohmeda, Englewood, CA), chest electrocardi-
ography (Lead I) and oxygen saturation (SpO2; ﬁnger pulse
oximeter). Figure 1 summarizes the instrumentation after the
patients had been connected to the mechanical ventilator (as
described below). Patients were deliberately not told how long
they might be expected to breath-hold, nor how long others
Table 1. Treatment with chemotherapy and trastuzumab during the breath-holding study
Subjects Chemotherapy
Days before breath-hold when last
chemotherapy given
Trastuzumab treatment during
breath-hold
1 FEC-T 124 Trastuzumab
2 FEC-T 134 None
3 ECMF 26 None
4 ECMF 136 None
5 FEC-T 67 None
6 FEC-T 41 None
7 FEC-T 96 None
8 FEC-T 107 None
9 FEC-T 180 None
10 None * None
11 FEC-T 159 None
12 None * None
13 None * None
14 Taxotere/cyclophosphamide 50 None
15 FEC-T 138 Trastuzumab
C, cyclophosphamide; E, epirubicin; F, 5 flurouracil; M, methotrexate; T, docetaxel.
*indicates not applicable.
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were holding. Patients did not know when the breath-hold
would start, were not allowed to see a clock during breath-
holding and listened to music throughout. We followed the
safety limits we described previously,18 with patients being
instructed to break their breath-hold if their systolic blood
pressure (sBP) consistently exceeded 180mmHg and/or SpO2
fell below 94%. Table 2 shows the order of the experimental
conditions (and their resulting breath-holds are given in
Figure 2). For their ﬁrst ever breath-hold with air (Table 2, order
1), patients breathed freely and were merely asked to breath-
hold as long as possible. This was measured with a stopwatch.
All were connected via a facemask to a Draeger Evita 2 ventilator
(Drager, Lubeck, Germany) and familiarized to spontaneous
breathing on the ventilator (on its assisted spontaneous
breathing setting) and to being mechanically hyperventilated by
the ventilator (on its intermittent positive-pressure ventilation
setting).16220
They were then instructed on how best to maintain a relaxed
posture, to inhale, exhale and inhale air maximally and to
breath-hold by closing their mouth and pharyngeal valve. Nose
clips were not used. They were taught not to attempt pushing or
inhaling against a closed glottis and this was easily conﬁrmed17,21
by observation of their chest and neck and of their blood
pressure record during experiments. They were told that they
were safe to try breath-holding longer, as their safety was con-
tinuously monitored and they would be instructed to stop if they
reached our safety limits. To measure the breath-hold duration
objectively from airway pressure and the partial pressure of
carbon dioxide in the expired gas, we used the disposable face-
mask with a pressure transducer (Digitimer Ltd, Hertfordshire,
UK) and an in-line capnograph (Hewlett–Packard 78536A cap-
nograph; Hewlett Packard®, Palo Alto, CA). End-tidal partial
pressure of carbon dioxide (PetCO2) measurements conﬁrmed
that they did not surreptitiously hyperventilate before breath-
holding. PetCO2 and mask pressure measurements also ensured
that they did not take surreptitious breaths during breath-holding.
Mechanical ventilation on spontaneous and positive-
pressure ventilation settings
After initial training, patients breathed air spontaneously
through the facemask connected to the ventilator and this was
recorded for a 4-min resting period. They then inhaled air
maximally, exhaled maximally and then inhaled maximally to
breath-hold as long as possible (Table 2, order 2). Following
recovery (about 2min), they breathed 60% oxygen spontane-
ously through the facemask connected to the ventilator. This is
the maximum percentage for pre-oxygenation that may safely be
given for breath-holding without increasing the risk of atelec-
tasis.18 After 4min of this, they breath-held again as long as
possible (Table 2, order 3). After recovery, they were then
mechanically hyperventilated through the facemask with posi-
tive pressure in 60% oxygen at a 16–17 breaths per minute
rhythm and at a tidal volume (approximately 1.2 l depending
on their size) to induce hypocapnia. We maintained hypo-
capnia at the mean PetCO2 level of 206 0mmHg (the lowest
level of hypocapnia that can be safely induced that causes
paraesthesiae without causing hypocapnic tetany).16,20,22,23
After 15min of hypocapnia, mechanical hyperventilation was
switched off and patients were instructed to inhale 60% oxygen
maximally, exhale maximally, inhale maximally and then
breath-hold (Table 2, order 4). Only at the end of the day were
patients told how long they had breath-held in each session.
Patients were thoroughly debriefed at the end of each day to
discuss what they felt and to reach agreement on what could be
performed the next day to improve their performance.
On subsequent sessions (approximately Days 2–4), we practised
only the breath-hold with pre-oxygenation and hypocapnia until
we and the patients felt it had stabilized at the maximum du-
ration with which each was comfortable (Table 2, order 5).
In the ﬁnal session (Day 5), patients went to a simulator room in
the Department of Radiotherapy containing an Osiris surface
image-mapping system (Qados Ltd, Berkshire, UK) and the
same equipment.19
They listened to music, wore a gown and lay on a breast board as
shown in Figure 1 to mimic every aspect of radiotherapy (except
Figure 1. Equipment on the patient during mechanical ventila-
tion in the simulator room. BP, blood pressure; ECG, electro-
cardiography; PCO2, partial pressure of carbon dioxide; SpO2,
oxygen saturation. Reproduced from Parkes et al19 with
permission from The British Institute of Radiology.
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for turning on the beam). Osiris markers were ﬁxed on the gown
in the following positions: right lateral, chest centre, left lateral
and left breast. We chose not to ﬁx the markers directly on their
skin to preserve patient modesty and to ensure that they remained
as relaxed as possible. Thenceforth, the marker positions were
recorded continuously to derive their x, y and z positions to the
nearest 0.1mm.19 We then repeated the breath-hold following
pre-oxygenation and hypocapnia (Table 2, order 6).
All physiological data were sampled at 2 kHz and recorded,
stored and analyzed using a CED1401 data acquisition system
(Cambridge Electronics Design, Cambridge, UK). The timing
Table 2. Order of experimental conditions
Order Condition Session
1 First ever breath-hold, with a maximum inﬂation with air 1
2
Instruction and training in breath-hold technique; patient connected to
mechanical ventilator but only on the spontaneous setting, inhale,
exhale, inhale maximally and then breath-hold from air after instruction
1
3
As (2) above, but after breathing 60% oxygen for 4min, then breath-hold
from 60% oxygen
1
4
As (3) above, but after 15min of mechanical ventilation-induced
hypocapnia with 60% oxygen, then breath-hold from 60% oxygen and
hypocapnia
1
5
As (4) above, repeated as necessary for post-training breath-hold from
60% oxygen and hypocapnia
2–4
6
As (5) above, repeated in simulator room under simulated treatment
conditions, then treatment table breath-hold from 60% oxygen and
hypocapnia
5
Figure 2. Mean breath-hold durations of.5min in 15 patients with breast cancer. ns p-value.0.05, *p-value,0.05, **p-value,0.01,
***p-value,0.001 by paired t test.
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of the Osiris data recordings was synchronized ofﬂine with all
other physiological data recordings. We described previously18
how we derived instantaneous heart rate, systolic, diastolic,
mean pressure and SpO2 and resampled data to align the data
correctly in all patients at the same time relative to the start
and end of breath-holding.
Statistical analysis
Statistical analysis was performed with paired comparisons
within patients and unpaired comparisons with the data from
our healthy subjects18 using analysis of variance for repeated
comparisons or Student’s t-test for single comparisons. Signiﬁ-
cance was taken at p-value, 0.05 for two-tailed tests, and means
are given with 6standard error of the mean. Detailed mathe-
matical analysis of the blood pressure changes between 20 and
100% of breath-holds used least-squares linear regression anal-
ysis. We assessed the adequacy (correlation coefﬁcient squared;
r^ 2) of a straight line ﬁt or whether ﬁtting two lines was sig-
niﬁcantly better than ﬁtting one line and have expressed slopes
as millimetre of mercury per minute (at percentage times of the
mean breath-hold duration).
RESULTS
Breath-hold durations
Figure 2 shows the mean breath-hold durations of all patients.
On Day 1 (Table 2, row 1), all could hold initially for 4262 s (and
none,29 s). Instruction (Table 2, row 2) signiﬁcantly increased the
mean breath-hold duration with air to 5866 s. Pre-oxygenation
signiﬁcantly increased the mean breath-hold duration to 1.66
0.1min and adding hypocapnia increased it to 2.960.3min.
Figure 3. Polygraph of the longest breath-hold (6.6min) under simulated treatment conditions. The left breast marker movement is
indicated as left to right (l to r), superior to inferior (sup to inf) and anterior to posterior (ant to post). The slope is calculated as
indicated between the vertical lines. bpm, beats per minute; mmHg, millimetre of mercury; PetCO2, end-tidal partial pressure of
carbon dioxide; SpO2, oxygen saturation.
Full paper: .5min breath-holds in patients with cancer BJR
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Performance signiﬁcantly and progressively improved with prac-
tice on subsequent days, with the longest breath-hold in the
practice room category reaching a mean of 5.16 0.2min. Even
the eldest patient (74 years) held for 5.3min.
Such breath-holds were safe. During training, none consistently
reached our safety limits (two patients reached the SpO2 limit
each on only one occasion, one of whom reaching the sBP limit
on a different occasion). At breakpoint, none were distressed,
nor experienced dizziness or disturbed breathing. All were un-
dergoing radiotherapy and there was no detectable effect on the
breath-hold duration of previous chemotherapy or current
trastuzumab treatment (Table 1).
Figure 3 shows the complete polygraph record for the subject
(aged 52 years) with the longest breath-hold (6.6min) in the
simulator room. This patient broke spontaneously just as she
reached the systolic pressure safety limit, whereas SpO2 was still
97% (and PetCO2 was 30mmHg). Figure 3 also shows that there
is some settlement in the anteroposterior position of the left
breast over the ﬁrst approximately 15 s of the breath-hold, before
the drift follows a linear trajectory.
Figure 2 shows that patients could reproduce their longest
breath-holds while on the breast board in the simulator room
(a mean of 5.36 0.2min). Under treatment conditions in the
simulator room breath-holds, patients did not consistently
reach the safety limits. In the simulator room, one patient
reached the SpO2 limit and two patients reached the systolic
pressure limit (none having previously reached these limits
during training). During all breath-holds, the chest deﬂates
slightly. Table 3 shows that during breath-holding, the mean
movement of all markers in the anteroposterior (z) direction
was ,2.2mmmin21.
Patient physiological responses at rest and
during breath-holding
During the 4-min rest period and while breathing air, the
patient’s mean sBP was 1316 5mmHg, averaged mean pressure
was 836 2mmHg, diastolic pressure was 596 2mmHg, mean
heart rate was 7562 beats per minute (bpm), mean PetCO2 level
was 3261mmHg and mean SpO2 was 996 0%. Pre-oxygenation
lowered the resting heart rate by 2 bpm (p-value, 0.05) and
this with hypocapnia raised the resting heart rate by 4 bpm
(p-value, 0.05), but these had no signiﬁcant effects on the
resting blood pressure. We found similarly small or no such
changes in the resting heart rate and blood pressure in previous
studies with pre-oxygenation and hypocapnia.16218,20
Figure 3 shows the cardiovascular changes in one patient. Figure 4a
shows that breath-holding caused signiﬁcant increases in mean sBP
(reaching for air 16067mmHg, for pre-oxygenation 15565 and
for pre-oxygenation with hypocapnia 16864mmHg). The failure
of the heart rate to fall (Figure 4b) conﬁrms that the heart
rate component of the baroreﬂex is attenuated during
breath-holding.18 Indeed at breakpoint, the mean heart
rate actually rose slightly from resting levels, by 6 bpm
(p-value, 0.05) for breath-holds with pre-oxygenation and by
12bpm (p-value, 0.05) for breath-holds with pre-oxygenation
and hypocapnia (Figure 4b).
Furthermore, Figure 4 shows that the mean pressure rise was
the same (i.e. it was not abolished) with pre-oxygenation and
hypocapnia, conﬁrming that the pressure rise is not caused by
a systemic chemoreﬂex.18 Figure 4 shows that the mean sys-
tolic pressure always returned to resting levels within 20 s of
the breakpoint.
Similarity of patients’ physiological responses to
those of healthy untrained subjects
The mean resting heart rate of patients was not signiﬁcantly
different from that of our healthy untrained subjects,18 although
the mean sBP of the patients was lower (by 3–12mmHg,
p-value, 0.05) and the mean resting PetCO2 level was lower (by
6mmHg, p-value, 0.001).
After sufﬁcient practice with pre-oxygenation and hypocapnia,
patients’ mean breath-hold duration was not signiﬁcantly shorter
than that in our untrained normal subjects—5.560.5min.18
At the breakpoint for breath-holds with air, patients had similar
systolic pressure levels, sPO2 levels (reaching a nadir of 986 1%
at 15 s post breakpoint) and PetCO2 levels (to 446 1mmHg).
Patients did, however, have a slightly higher mean heart rate at
breakpoint (by 7 bpm, p-value, 0.05).
At breakpoint from pre-oxygenation and hypocapnia, the mean
blood pressure and heart rate were higher in patients (by
15mmHg, p-value, 0.05, and by 12 bpm, p-value, 0.05) than
in healthy subjects.
Table 3. Slight chest deflation during breath-holding
Anteroposterior (z) movement of Mean mmmin21 SE mmmin21 n
Left breast marker 21.9 0.3 15
Chest marker 22.1 0.3 11
Left lateral marker 21.1 0.3 14
Right lateral marker 21.1 0.2 14
Mean superior/inferior (y) movement of all markers 0.1 0.1 11
Mean left/right (x) movement of all markers 20.6 0.2 11
SE, standard error.
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Detailed mathematical analysis of the course of the blood
pressure rises during breath-holding in both patients (Figure 4a)
and healthy volunteers in our previous study18 showed that
throughout breath-holds with air and with oxygen, the better ﬁt
for both was a small but linear rise in pressure (for patients, the
air slope was 7mmHgmin21 and the oxygen slope was
6mmHgmin21 and for normal subjects, the air and oxygen
slopes were both 6mmHgmin21). Whereas, for breath-holds
with pre-oxygenation and hypocapnia, the better ﬁt for both was
a small linear rise for the ﬁrst 75% of the breath-hold (patient
slope of 1mmHgmin21 and normal subject slope of
8mmHgmin21), followed by a steeper rise over the last 25% of
the breath-hold (patient slope of 20mmHgmin21 and normal
subject slope of 18mmHgmin21).
DISCUSSION
We show for the ﬁrst time that patients with cancer undergoing
radiotherapy can be trained to deliver safely and under treat-
ment conditions a single breath-hold of .5min. This is .10
times longer than currently used in radiotherapy practice. Our
technique may offer opportunities to improve imaging and
radiotherapy delivery for a wide range of thoracic and abdom-
inal tumours.
Breath-hold durations
The .5-min breath-hold durations we achieved in patients with
breast cancer are not signiﬁcantly different from those we ach-
ieved in similarly inexperienced and much younger healthy
volunteers.18 Much longer durations have been achieved by us17
and others,23 before safety was such an overt consideration.
Indeed we have achieved breath-hold durations of up to 12min
in some healthy volunteers that are still within our safety limits
[MJ Parkes et al, personal communication]. Further research is
still required to understand how some but not all achieve this,
and such research might beneﬁt patients who are more anxious
or have compromised lung function.
Success appears to be due to the combination of training,
practice, pre-oxygenation and mechanically induced hypo-
capnia, rather than any one particular element. Others24 used
our basic methodology but with voluntary hyperventilation and
achieved mean durations in patients with breast cancer of
Figure 4. Blood pressure rises linearly (without heart rate falling) during breath-holding in 15 patients: (a) mean systolic blood
pressure. (b) Mean heart rate lines refer to breath-holds with air (grey line), pre-oxygenation (thin black line) and pre-oxygenation
with hypocapnia (thick black line). ns p-value.0.05, *p-value,0.05 by analysis of variance (ANOVA) and paired t test. mmHg,
millimetre of mercury; SE, standard error.
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2.8min. The advantage of patients voluntarily hyperventilating
is that it requires less equipment; but, the disadvantage is that
the level of hypocapnia is much harder to control. Furthermore,
voluntary hyperventilation requires much concentration and
physical effort from patients. Voluntary hyperventilation in
combination with the above elements may well have clinical
application, if routine single and prolonged breath-holds of
under approximately 3-min duration are required. But, we be-
lieve that most patients will ﬁnd voluntary hyperventilation too
difﬁcult, whereas we know they ﬁnd mechanical hyperventila-
tion straightforward.19 This fact, in combination with the time
required for ﬁnal positioning, staff leaving the room and beam
delivery checks for setup, indicates to us that if single and
prolonged breath-holds have widespread application in radio-
therapy, resources would be best applied to develop mechanical
rather than voluntary hyperventilation. Furthermore, single
prolonged breath-holds would have no detrimental effects on
clinical efﬁciency, since all training could be achieved by non-
radiotherapy staff at a separate location for as long as necessary
for each patient. This is of particular importance in very high-
cost applications such as proton and particle beam radiotherapy,
where time spent in the treatment room is at a premium. With
our technique, only when fully trained would patients attend the
radiotherapy department.
For routine clinical delivery of single prolonged breath-holds, we
therefore recommend developing a simpliﬁed ventilator for ra-
diotherapy use together with non-invasive measurement of
PetCO2 to control the depth of hypocapnia achieved. Our rec-
ommendations18 for patient safety during breath-holding should
be followed, requiring non-invasive equipment to measure SpO2
and sBP.
Linear chest movement during single and
prolonged breath-holds
The chest normally deﬂates slightly (by approximately
300mlmin21)25 during all breath-holds because metabolism
results in gaseous oxygen continuing to be extracted from al-
veolar air, whereas an equal volume of gaseous carbon dioxide
cannot escape from blood into alveolar air to replace it.14 Since
there is no reason for the metabolic rate to ﬂuctuate during
breath-holding, the rate of this deﬂation should be linear. Our
direct measurements establish that it is. The largest deﬂation
movement (,2.2mmmin21) is in the anteroposterior direction,
but we may have overestimated all such movements, ﬁrst be-
cause our markers were placed on the gown rather than on
the skin and secondly because our drift measurement includes
the initial settlement in position over the ﬁrst approximately
15 s of the breath-hold. The size of this linear deﬂation
movement during single prolonged breath-holds is far smaller
than the rhythmic 2–3 cm of movement measured during
breathing in radiotherapy studies.1 It should be straightfor-
ward to predict the trajectory of this linear movement during
treatment planning by measuring it when patients are asked
to mimic it by slowly exhaling the same volume. Another
possibility is to abolish this deﬂation movement altogether.
This could be achieved by using the mechanical ventilator to
reinﬂate the chest at a rate equivalent to the metabolic rate
(rate of oxygen consumption) during the breath-hold.
Patient recruitment and experience
With no previous experience of training any patients with cancer
for single prolonged breath-holds, we initially believed that
single and prolonged breath-holds would be achieved only in
patients who are relatively young, ﬁt and exercise conscious.
We were not able to recruit such patients. Instead, we were only
able to recruit 15 older patients (a mean age of 54 years). But, we
found that breath-hold duration was not obviously related to
age. We were cautious with our ﬁrst few patients and were
satisﬁed with 3–4-min breath-holds. With the experience gained
with later patients, however, we now believe we could have
trained the ﬁrst patients to hold even longer.
Similarly, with no previous experience, we devised rigorous
exclusion criteria, had trained resuscitation staff available and set
cautious safety limits for breath-hold termination. We could
now relax some of these exclusion criteria to recruit a more
representative range of the patient population. But, we would
still retain the initial health screening and we would not with-
draw our safety limits.
All patients were volunteers, motivated to help other patients,
but the experience gained would now enable us to involve more
reserved patients. All continued with radiotherapy during our
training and while 12 patients also had had chemotherapy and
2 patients were receiving trastuzumab, these had no effect on
breath-hold duration. We saw no evidence that patient perfor-
mance decreased over time, while radiotherapy treatment con-
tinued. Indeed, we feel we gave our patients relatively little
training. We would not be surprised if breath-hold durations
continued to improve as they become part of multiple treatment
sessions.
Wider applications for radiotherapy practice
While our pilot study focused on patients with breast cancer, the
results will be representative of all patients with normal lung
function. Our approach could therefore be of beneﬁt to patients
with tumours in a wide range of thoracic and abdominal loca-
tions including the lung, oesophagus, liver, pancreas, stomach
and kidney. Management of respiratory-related motion at all
these sites is the subject of urgent ongoing research and technical
modiﬁcations. Our pilot data indicate that our novel approach
should be brought into this debate.
For patients with varying degrees of compromised lung func-
tion, there is a particular need for investigating their tolerance of
our technique. But, patients with all levels of compromised lung
function are routinely ventilated while under general anaesthesia, as
dictated by clinical needs. Moreover, when conscious, these patients
should ﬁnd mechanical ventilation more comfortable than spon-
taneous breathing, because mechanical ventilation abolishes the
effort of breathing. Our next focus therefore is on the feasibility of
our technique in patients with compromised lung function.
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